Latest News

Tuesday May 25, 2021

  Dale Godfrey What was your first job? Newspaper delivery boy (The Herald – an afternoon newspaper back in the day).   What are you currently watching on TV? In between TV shows right now, but just finished Schitt’s Creek, which was excellent (yes, I know, it is quite old now, but I was a slow starter).   Which celebrity would you like to meet for a cup of coffee? Jerry Seinfeld.   What would you sing at Karaoke night? Paradise by the dashboard light. In fact, I did sing that at a Karaoke ...
More...

Tuesday March 23, 2021

More COVID relief for members: Free 2021 Student Memberships Applicable to student renewals received between Jan 1st - April 1st 2021 Great news for students! Given the challenging times we are in, we recently showed our support for members by announcing the new ASI Career Advancement Awards and the Carer Awards - COVID support. Today we have more great news!  We are pleased to inform our student members that their 2021 ASI membership will be reimbursed to them.    This fantastic offer is applicable to both ...
More...

Tuesday March 09, 2021

We welcome our new ASI Sustaining Member: Cayman Chemical   Our ASI Sustaining Members recognise the importance of supporting ASI and Immunology researchers in Australia and New Zealand.  We are grateful and proud to introduce our newest ASI Sustaining Member: Cayman Chemical. Helping Make Research Possible Cayman Chemical is a global provider of life science products and services to advance biomedical research and enable new therapies. Specializing in chemical synthesis, assay and antibody development, and preclinical drug discovery, Cayman creates and supplies small molecules, assay kits, antibodies, and ...
More...

Monday February 22, 2021

We welcome our new ASI Sustaining Member: PeproTech   Our ASI Sustaining Members recognise the importance of supporting ASI and Immunology researchers in Australia and New Zealand.  We are grateful and proud to introduce our newest ASI Sustaining Member: PeptroTech. About PeproTech PeproTech creates the building blocks of your life science research by manufacturing high-quality products that advance scientific discovery and human health.  Since 1988, we have grown into a global enterprise with state-of-the-art manufacturing facilities in the US, and offices around the world.   With over 2,000 products, ...
More...

Friday December 11, 2020

  Senga Whittingham As a child, what did you want to be when you grew up? A poet. I grossly over-estimated my talents. How many hours of sleep do you get? Varies. How many coffees/ teas do you drink per day? During lockdown a cup of coffee at the end of a walk proved therapeutic, and the number of teas are those required to maintain fluid balance. Which immune cell is your favourite?  The B lymphocyte.   The B lymphocyte was yet unnamed in 1960 when overnight I underwent my conversion ...
More...

Friday October 23, 2020

We welcome our new ASI Sustaining Member: GenScript   Our ASI Sustaining Members recognise the importance of supporting ASI and Immunology researchers in Australia and New Zealand.  We are grateful and proud to introduce our newest ASI Sustaining Member: GenScript. About GenScript Genscript is the world’s leading biotech company providing life sciences services and products.   With gene synthesis, oligo, CRISPR, peptide, protein, antibody and preclinical drug development service capabilities, we are internationally recognized as a leading biotech company specializing in fundamental life sciences research and early-phase ...
More...

Thursday October 22, 2020

More COVID relief for members: Free 2021 Student Memberships Applicable to student renewals received between Jan 1st - April 1st 2021 Great news for students! Given the challenging times we are in, we recently showed our support for members by announcing the new ASI Career Advancement Awards and the Carer Awards - COVID support. Today we have more great news!  We are pleased to inform our student members that their 2021 ASI membership will be reimbursed to them.   This fantastic offer is applicable to both ...
More...

Wednesday September 02, 2020

We welcome our new ASI Sustaining Member: Nanostring   Our ASI Sustaining Members recognise the importance of supporting ASI and Immunology researchers in Australia and New Zealand.  We are grateful and proud to introduce our newest ASI Sustaining Member: Nanostring. About Nanostring NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research. The company's technology enables a wide variety of basic research and translational medicine applications.   Nanostring's commitment to research The Singapore Immunology Network (SIgN) & NanoString, in collaboration with Illumina, co-sponsor a research award ...
More...

Tuesday May 05, 2020

Dear ASI member, The ASI Constitution now contains some important new rules that may affect your membership. To simplify our membership requirements, the most recent ASI AGM introduced a renewal deadline of June 30th. After this date, any members who have not yet renewed will no longer be an ASI member, and therefore cease to have membership benefits, including access to member-only content on our website. If you haven't already, please endeavour to pay your membership renewal fee now (or before June 30th 2020) to ...
More...

Friday April 24, 2020

  Anne Kelso Tea or coffee? Coffee! Black for breakfast and a flat white mid-morning and all is right with the world. What is your favourite dessert? Anything with chocolate, one of the essential food groups that deserves its own chapter in NHMRC’s Australian Dietary Guidelines. As a child, what did you want to be when you grew up? Scientist, actually. My best friend in primary school wanted to be a doctor (she is), I wanted to be a scientist and together we were going to cure ...
More...

Wednesday April 22, 2020

The ASI Special Initiatives Fund We recently launched the ASI Special Initiatives Fund - a unique opportunity where you can help us move ASI into the future and advance our discipline. In 2017 we committed AUD 200 000 toward the Special Initiatives Fund, and invited ideas for novel initiatives from ASI members. Today we invite ASI members to send in their novel ideas for the next Special Initiatives Funding Round. Purpose New initiatives should be within the scope of the society and to the benefit of ...
More...

Friday April 17, 2020

Connecting ECR's and students  We know you'll be missing student and ECR functions this year, whether it be at your local branch meeting or at our annual meeting. So, as the next best thing we've established an online support network just for ECR's and students. Join the ASI Support Network Join the network. Meet other ECR's and students. Chat about everything and nothing. Sound like exactly what you need right now? If so, register now, and have a chat with new (or old) friends.  What's ...
More...

Friday April 10, 2020

ASI Members now have special access to Digital Resources Not that you need another reason to be an ASI Member... But, today we launch our new initiative - ASI Digital Resources! This is the start of a great collection of useful things to know, to survive in scientific research. They have been created by recording some of the postgraduate talks from ASI 2019 Adelaide - so if you missed them, here's your chance to brush up on these skills! Creating this new ASI initiative would ...
More...

Monday March 30, 2020

Message from ASI President to membership Dear ASI Members, It is with great sadness that we inform our members of the passing of Professor Ian Mackay at the age of 98. Professor Mackay was an ASI Honorary Life Member and is widely recognised as a pioneering Australian immunologist in the field of autoimmune disease. With much gratitude, we would like to thank Len Harrison, WEHI, for the obituary below. Ngā mihi John Fraser, ASI President Obituary written by Leonard Harrison, WEHI It was with great sadness that we learnt of ...
More...

Sunday March 08, 2020

In the lead-up to International Women's Day, here at ASI, we are celebrating women and men in all their diversities. March 8th is a great day to recognise just how far ASI has come toward achieving gender equity and embracing diversity and inclusion. Take a minute to: Remind your colleagues who may be on parental leave that we are offering onsite childcare again this year at ASI 2020 Auckland. Check out the progress we've made toward achieving gender equity amongst our Invited Speakers - click here Spread ...
More...

Thursday March 05, 2020

  Roslyn Kemp     How many coffees / teas do you drink per day?  I drink one store-bought coffee a day – I don’t really like hot drinks, but that preference became such a social handicap when I moved back to NZ that I had to start.   Which immune cell is your favourite? The T cell, of course - many will be aware of my opinion that all T cells can do all things in the immune response depending on where it is and who is ...
More...

Thursday February 20, 2020

2020 Membership Renewal Invoices are now available for payment We warmly welcome our new ASI Members and many thanks to all of our members on auto-renewal. Membership invoices are now ready for payment so please log in to your ASI Member Profile and click on the 'Invoices' tab.   Make sure you're eligible for 2020 awards by renewing now Don't forget that eligibility for most ASI awards require renewal before April 1st so please renew now by clicking the green button below. We warmly welcome our ...
More...

Thursday January 23, 2020

The Editorial Board of Clinical & Translational Immunology is looking for early and mid-career ASI investigators to act as Guest Editors for the journal. Guest Editors will be responsible for coordinating theme-specific Special Features of Clinical and Translational Immunology for 2020-21 which can include primary research papers and/or comprehensive reviews.  If you are interested in acting as Guest Editor, please email the Clinical & Translational Immunology Editorial Office ([email protected]) with the potential title of the theme and a list of potential contributors to this Special Feature. In addition, please include brief ...
More...